Galectin-3: Relation to infarct scar and left ventricular function after myocardial infarction

International Journal of Cardiology

Volumn 163, Issue 3, 2013, Pages 335-337

  Mayr, Agnes ^a   Klug, Gert ^a   Mair, Johannes ^a   Streil, Katrin ^a   Harrasser, Bettina ^a   Feistritzer, Hans Josef ^a   Jaschke, Werner ^a   Schocke, Michael ^a   Pachinger, Otmar ^a   Metzler, Bernhard ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Cardiac magnetic resonance imaging; Galectin 3; Myocardial function; Myocardial infarction scar

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE; GALECTIN 3;

ADULT; CARDIAC IMAGING; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; IMAGE ENHANCEMENT; LETTER; NUCLEAR MAGNETIC RESONANCE SCANNER; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REPRODUCIBILITY; SCAR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; MYOCARDIAL INFARCTION SCAR; PROGNOSIS;

EID: 84874521749     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.06.087     Document Type: Article

References (19)

1. R.A. de Boer, A.A. Voors, P. Muntendam, W.H. van Gilst, and D.J. van Veldhuisen Galectin-3: a novel mediator of heart failure development and progression Eur J Heart Fail 11 2009 811 817
2. U.C. Sharma, S. Pokharel, and T.L. van Brakel Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction Circulation 110 2004 3121 3128
3. U. Sharma, N.E. Rhaleb, and S. Pokharel Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage Am J Physiol Heart Circ Physiol 294 2008 H1226 H1232
4. R.M. Conroy, K. Pyörälä, A.P. Fitzgerald 987-1003 Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur Heart J 24 2003 987 1003
5. J. Dumic, S. Dabelic, and M. Flögel Galectin-3: an open-ended story Biochim Biophys Acta 1760 4 Apr 2006 616 635 [Epub 2006 Jan 18. Review]
6. R.Y. Yang, G.A. Rabinovich, and F.T. Liu Galectins: structure, function and therapeutic potential Expert Rev Mol Med 10 Jun 13 2008 e17
7. R.J. Kim, D.S. Fieno, and T.B. Parrish Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function Circulation 100 1999 1992 2002
8. T. Ibrahim, S.G. Nekolla, and M. Hornke Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99m-sestamibi J Am Coll Cardiol 45 2005 544 552
9. G. Klug, T. Trieb, and M. Schocke Quantification of regional functional improvement of infarcted myocardium after primary PTCA by contrast-enhanced magnetic resonance imaging J Magn Reson Imaging 29 2 Feb 2009 298 304
10. A. Mayr, J. Mair, and M. Schocke Predictive value of NT-pro BNP after acute myocardial infarction: relation with acute and chronic infarct size and myocardial function Int J Cardiol 147 1 Feb 17 2011 118 123 [Epub 2009 Nov 7]
11. A. Mayr, G. Klug, and M. Schocke Late microvascular obstruction after acute myocardial infarction: relation with cardiac and inflammatory markers Int J Cardiol 157 3 Jun 14 2012 391 396 [Epub 2011 Jan 15]
12. E.W. Grandin, P. Jarolim, and S.A. Murphy Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22 Clin Chem 58 1 Jan 2012 267 273 [Epub 2011 Nov 22]
13. R.V. Shah, A.A. Chen-Tournoux, M.H. Picard, R.R. van Kimmenade, and J.L. Januzzi Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure Eur J Heart Fail 12 8 Aug 2010 826 832 [Epub 2010 Jun 5]
14. W.H. Tang, K. Shrestha, and Z. Shao Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival Am J Cardiol 108 3 Aug 1 2011 385 390 [Epub 2011 May 19]
15. R.R. van Kimmenade, J.L. Januzzi Jr., and P.T. Ellinor Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure J Am Coll Cardiol 48 6 Sep 19 2006 1217 1224 [Epub 2006 Aug 28]
16. G.M. Felker, M. Fiuzat, and L.K. Shaw Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study Circ Heart Fail 5 1 Jan 1 2012 72 78 [Epub 2011 Oct 20]
17. G. Tjeerdsma, R.A. de Boer, F. Boomsma, M.P. van den Berg, Y.M. Pinto, and D.J. van Veldhuisen Rapid bedside measurement of brain natriuretic peptide in patients with chronic heart failure Int J Cardiol 86 2-3 Dec 2002 143 149 [discussion 149-52]
18. H. Milting, P. Ellinghaus, and M. Seewald Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices J Heart Lung Transplant 27 6 Jun 2008 589 596
19. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150